Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-019623
Filing Date
2024-04-12
Accepted
2024-04-12 16:20:02
Documents
23
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20024279x2_def14a.htm   iXBRL DEF 14A 2805400
6 logo_cooley.jpg GRAPHIC 25946
7 logo_immunocore.jpg GRAPHIC 29929
8 ny20024279x2_barchart01.jpg GRAPHIC 114845
9 ny20024279x2_linechart01.jpg GRAPHIC 179827
10 ny20024279x2_pc01.jpg GRAPHIC 1303266
11 ny20024279x2_pc02.jpg GRAPHIC 936189
12 ny20024279x2_pvpchart01.jpg GRAPHIC 204472
13 ny20024279x2_pvpchart02.jpg GRAPHIC 180667
  Complete submission text file 0001140361-24-019623.txt   11658888

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA imcr-20240523.xsd EX-101.SCH 5099
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE imcr-20240523_def.xml EX-101.DEF 5854
4 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE imcr-20240523_lab.xml EX-101.LAB 11427
5 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE imcr-20240523_pre.xml EX-101.PRE 5186
26 EXTRACTED XBRL INSTANCE DOCUMENT ny20024279x2_def14a_htm.xml XML 252940
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39992 | Film No.: 24841744
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)